RSV Roundtable: Disease education, vaccine hesitancy, and awareness
In the second installment of RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
EP: 1.RSV Roundtable: What clinicians are witnessing in terms of RSV incidence
EP: 2.RSV Roundtable: Disease education, vaccine hesitancy, and awareness
EP: 3.RSV Roundtable: Nirsevimab's impact
EP: 4.RSV Roundtable: Addressing the senior population
EP: 5.The clinical takeaways of the RSV immunizations
EP: 6.RSV this year: Clinician insights and urgent vaccination strategies
Welcome to the second episode of our 5-episode series; respiratory syncytial virus (RSV) Roundtable, a collaborative project from Contemporary Pediatrics, Contagion, and Contemporary OB/GYN.
This series discusses several aspects of RSV including incidence rates, vaccines, and immunizations.
In this episode, our panel breaks down disease education and discusses how parents have reacted to the new preventive tools nirsevimab (Beyfortus; Sanofi, AstraZeneca) and RSVpreF (Abrysvo; Pfizer). In addition, the panel explains how vaccine hesitancy and limited availability of nirsevimab has made an impact this RSV season.
Our panel of clinicians includes:
- Robert H. Hopkins Jr., MD: medical director, National Foundation for Infectious Diseases; professor of Internal Medicine and Pediatrics; chief, Division of General Internal Medicine, University of Arkansas for Medical Sciences
- William Muller, MD, PhD: attending physician, Infectious Diseases; Ted Emerson Miller research scholar; professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine; scientific director, Clinical and Community Trials, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children’s Hospital
- Sallie Permar, MD, PhD: Nancy C. Paduano professor and chair, Department of Pediatrics, Weill Cornell Medicine; pediatrician-in-chief, New York-Presbyterian/Weill Cornell Medical Center
- Laura Riley, MD: chair, Department of Obstetrics and Gynecology, Weill Cornell Medicine; obstetrician and gynecologist-in-chief, New York-Presbyterian/Weill Cornell Medical Center
- Neil Silverman, MD: professor, obstetrics and gynecology, David Geffen School of Medicine, UCLA; director, Maternal-Fetal Medicine Fellowship Program
For the first episode of RSV Roundtable, click here.
This series will release a new episode every Friday through January 5, 2024.
The Role of the Healthcare Provider Community in Increasing Public Awareness of RSV in All Infants
April 2nd 2022Scott Kober sits down with Dr. Joseph Domachowske, Professor of Pediatrics, Professor of Microbiology and Immunology, and Director of the Global Maternal-Child and Pediatric Health Program at the SUNY Upstate Medical University.
